|
|
| Week of Expected Pricing |
Withdrawn |
| Company Name |
VIEWRAY INC |
| Proposed Ticker |
VRAY |
| CUSIP |
92672W103 |
| Business Description |
Design, manufacture and market MRIdian, the first and only MRI-guided radiation therapy system that images and treats cancer patients simultaneously. |
| Lead Underwriter |
Cowen and Company, LLC, Stifel Nicolaus & Company, Incorporated |
| Co-Managers |
Brean Capital, LLC, BTIG, LLC |
| Initial Shares |
4,000,000 |
| Revised Initial Shares |
N/A |
| Initial Price |
$12.00-$14.00 |
| Revised Price |
N/A |
| Final Price |
N/A |
| Final Ticker |
N/A |
|
|
|
|
